Mahal Jeetinder Singh 4
4 · Jasper Therapeutics, Inc. · Filed Dec 12, 2024
Insider Transaction Report
Form 4
Mahal Jeetinder Singh
DirectorCEO and President
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-12-12+900→ 13,772 totalExercise: $7.10Exp: 2030-05-31→ Voting Common Stock (900 underlying) - Sale
Voting Common Stock
2024-12-12$22.11/sh−900$19,899→ 25,009 total - Exercise/Conversion
Voting Common Stock
2024-12-12$7.10/sh+900$6,390→ 25,909 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
- [F2]25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.